Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) plays an integral role in several cellular processes, such as vesicular trafficking, autophagy, and the cellular stress response, primarily through its association with the Golgi apparatus. As a lipid-interacting protein, GAPR-1's activity is tightly regulated within cellular environments, ensuring proper membrane dynamics, vesicle formation, and trafficking. It functions by binding to specific lipid moieties within the Golgi membrane, influencing the organelle's structure and function. The ability of GAPR-1 to interact with various lipid species dictates its role in maintaining the integrity and functionality of the Golgi complex, making it a crucial component in the cellular response to environmental and internal stimuli.
Inhibition of GAPR-1 involves a complex interplay of molecular mechanisms that disrupt its normal function and interaction with lipid molecules within the Golgi apparatus. This can occur through several pathways, including alterations in lipid composition that affect GAPR-1's binding affinity, post-translational modifications that modify its structure or localization, and interactions with other cellular proteins that can sequester GAPR-1 away from its site of action. Specifically, changes in the phosphorylation status of GAPR-1 can lead to its inactivation or mislocalization, thereby impairing its ability to participate in membrane trafficking and autophagy. Furthermore, the modulation of lipid biosynthesis pathways can alter the availability of GAPR-1's lipid targets, effectively inhibiting its function by preventing its association with the Golgi membrane. Additionally, cellular stressors that induce changes in the cellular environment can lead to the upregulation of inhibitory proteins or signaling pathways that counteract GAPR-1's activity, thus inhibiting its role in maintaining Golgi structure and function. Through these mechanisms, the inhibition of GAPR-1 can have significant impacts on cellular homeostasis, affecting vesicle trafficking, membrane dynamics, and the cellular response to stress, highlighting the protein's critical role in cellular physiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, which is part of signaling pathways that may regulate GLIPR2-related processes in cancer cell proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A specific inhibitor of PI3K, potentially affecting GLIPR2 by altering cell survival signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, a kinase that can regulate processes potentially linked with GLIPR2 functions in cell growth. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor that can influence gene expression, potentially affecting GLIPR2 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Demethylating agent, can lead to changes in gene expression, possibly impacting GLIPR2 levels. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which is upstream of ERK; could affect signaling related to GLIPR2's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which might alter signaling pathways associated with GLIPR2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, potentially affecting signaling pathways involving GLIPR2. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
Inhibits EGFR tyrosine kinase, which may be upstream of pathways involving GLIPR2. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
A Src family kinase inhibitor, potentially affecting signaling related to GLIPR2. | ||||||